Literature DB >> 19460961

New era of personalized medicine: a 10-year anniversary.

Jan Trøst Jørgensen.   

Abstract

Mesh：

Year:  2009        PMID： 19460961     DOI： 10.1634/theoncologist.2009-0047

Source DB:  PubMed          Journal:  Oncologist        ISSN： 1083-7159


× No keyword cloud information.
  9 in total

Review 1.  Can genomic medicine improve financial sustainability of health systems?

Authors:  Christine Y Lu; Joshua P Cohen
Journal:  Mol Diagn Ther       Date:  2015-04       Impact factor: 4.074

2.  A Personalized Predictive Framework for Multivariate Clinical Time Series via Adaptive Model Selection.

Authors:  Zitao Liu; Milos Hauskrecht
Journal:  Proc ACM Int Conf Inf Knowl Manag       Date:  2017-11

3.  The n-of-1 clinical trial: the ultimate strategy for individualizing medicine?

Authors:  Elizabeth O Lillie; Bradley Patay; Joel Diamant; Brian Issell; Eric J Topol; Nicholas J Schork
Journal:  Per Med       Date:  2011-03       Impact factor: 2.512

4.  A framework for self-experimentation in personalized health.

Authors:  Ravi Karkar; Jasmine Zia; Roger Vilardaga; Sonali R Mishra; James Fogarty; Sean A Munson; Julie A Kientz
Journal:  J Am Med Inform Assoc       Date:  2015-12-07       Impact factor: 4.497

5.  A Patient-Centered Proposal for Bayesian Analysis of Self-Experiments for Health.

Authors:  Jessica Schroeder; Ravi Karkar; James Fogarty; Julie A Kientz; Sean A Munson; Matthew Kay
Journal:  J Healthc Inform Res       Date:  2018-09-25

6.  Evaluating the Individualized Treatment of Traditional Chinese Medicine: A Pilot Study of N-of-1 Trials.

Authors:  Haiyin Huang; Peilan Yang; Jingjing Xue; Jie Tang; Liyu Ding; Ying Ma; Jie Wang; Gordon H Guyatt; Thuva Vanniyasingam; Yuqing Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2014-11-11       Impact factor: 2.629

7.  Conceptual and terminological confusion around personalised medicine: a coping strategy.

Authors:  Giovanni De Grandis; Vidar Halgunset
Journal:  BMC Med Ethics       Date:  2016-07-18       Impact factor: 2.652

8.  Access to Guideline-Recommended Pharmacogenomic Tests for Cancer Treatments: Experience of Providers and Patients.

Authors:  Ann Chen Wu; Kathleen M Mazor; Rachel Ceccarelli; Stephanie Loomer; Christine Y Lu
Journal:  J Pers Med       Date:  2017-11-15

9.  Insurance Coverage Policies for Pharmacogenomic and Multi-Gene Testing for Cancer.

Authors:  Christine Y Lu; Stephanie Loomer; Rachel Ceccarelli; Kathleen M Mazor; James Sabin; Ellen Wright Clayton; Geoffrey S Ginsburg; Ann Chen Wu
Journal:  J Pers Med       Date:  2018-05-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.